Guangzhou Kingmed Diagnostics Group Co Ltd
KingMed Diagnostics's GHG Emissions Data Preview
In 2023, KingMed Diagnostics completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).
However, KingMed Diagnostics has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Location-Based | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into KingMed Diagnostics's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of KingMed Diagnostics amounted to 34,374.54 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of KingMed Diagnostics decreased by 6.51%, showing that the company has made progress in taking action to reduce the climate impact of its operations.
KingMed Diagnostics's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are KingMed Diagnostics's Scope 1 emissions?
In 2023, the total Scope 1 emissions of KingMed Diagnostics were 5,235.95 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Has KingMed Diagnostics reduced its Scope 1 emissions over time?
Since 2021, KingMed Diagnostics's Scope 1 emissions have decreased by 41.93%, reflecting a declining long-term trend in Scope 1 emissions over time.
Compared to the previous year (2022), KingMed Diagnostics's Scope 1 emissions decreased by 30.49%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.
What are KingMed Diagnostics's Scope 2 emissions?
In 2023, KingMed Diagnostics reported Scope 2 greenhouse gas (GHG) emissions of 29,138.59 tCOâ‚‚e using the location-based method.
Has KingMed Diagnostics reduced its Scope 2 emissions over time?
Since 2021, KingMed Diagnostics's Scope 2 greenhouse gas (GHG) emissions (Location-Based) have increased by 21.84%, reflecting a rising long-term trend in Scope 2 emissions over time.
Compared to the previous year (2022), KingMed Diagnostics's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that KingMed Diagnostics 's emissions have plateaued with no significant change in its energy consumption footprint.
What methodology does KingMed Diagnostics use for Scope 2 reporting?
In 2023, KingMed Diagnostics reported its Scope 2 emissions using the location-based method.
KingMed Diagnostics's Scope 2 Emissions Over Time
- Total Scope 2 Location-Based
Insights into KingMed Diagnostics's Total Carbon Footprint
In 2023, KingMed Diagnostics reported a total carbon footprint of 34,374.54 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 6.51% decrease compared to 2022, indicating progress in reducing its overall greenhouse gas output.
The largest contributor to KingMed Diagnostics's total carbon footprint was Scope 2 emissions, accounting for 84.77% of the company's total carbon footprint, followed by Scope 1 emissions at 15.23%.